Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis

Minoru Nakamura, Yasushi Takii, Masahiro Ito, Atsumasa Komori, Terufumi Yokoyama, Yuki Shimizu-Yoshida, Makiko Koyabu, Mutsumi Matsuyama, Tsuyoshi Mori, Takashi Kamihira, Manabu Daikoku, Kiyoshi Migita, Hiroshi Yatsuhashi, Naohito Nozaki, Shinji Shimoda, Hiromi Ishibashi

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The sustained antibody response to nuclear envelope gp210 antigen indicates a group of primary biliary cirrhosis (PBC) patients at high risk for the progression to end-stage hepatic failure. To address this issue, we immunohistochemically studied the expression of gp210 antigen in needle liver biopsy specimens from PBC patients using a monoclonal antibody specific for gp210 antigen. The specimens from autoimmune hepatitis (AIH), chronic viral hepatitis B (CHB) and C (CHC) patients served as disease controls. The expression of gp210 antigen was apparently increased on the nuclear envelope of biliary epithelial cells (BECs) of small bile ducts in almost all specimens from PBC. In contrast, the expression of gp210 antigen was negative in BECs of small bile ducts in normal liver, while relatively weak anti-gp210 immunostaining was observed in AIH, CHC and CHB. In addition, the degree of gp210 expression in BECs of small bile ducts was positively correlated to that of portal inflammation, interface hepatitis and lobular inflammation in PBC. These results indicate that the increased expression of gp210 in small bile ducts, which is probably associated with damage to BECs by inflammation, is possibly involved in autoimmune response to gp210 leading to the progression to end-stage hepatic failure in PBC.

Original languageEnglish
Pages (from-to)138-145
Number of pages8
JournalJournal of Autoimmunity
Volume26
Issue number2
DOIs
Publication statusPublished - Mar 1 2006

Fingerprint

Biliary Liver Cirrhosis
Nuclear Envelope
Bile Ducts
Antigens
Epithelial Cells
Autoimmune Hepatitis
Chronic Hepatitis B
Liver Failure
Inflammation
Liver
Needle Biopsy
Chronic Hepatitis C
Hepatitis C
Autoimmunity
Hepatitis
Antibody Formation
Monoclonal Antibodies

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Nakamura, M., Takii, Y., Ito, M., Komori, A., Yokoyama, T., Shimizu-Yoshida, Y., ... Ishibashi, H. (2006). Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. Journal of Autoimmunity, 26(2), 138-145. https://doi.org/10.1016/j.jaut.2005.10.007

Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. / Nakamura, Minoru; Takii, Yasushi; Ito, Masahiro; Komori, Atsumasa; Yokoyama, Terufumi; Shimizu-Yoshida, Yuki; Koyabu, Makiko; Matsuyama, Mutsumi; Mori, Tsuyoshi; Kamihira, Takashi; Daikoku, Manabu; Migita, Kiyoshi; Yatsuhashi, Hiroshi; Nozaki, Naohito; Shimoda, Shinji; Ishibashi, Hiromi.

In: Journal of Autoimmunity, Vol. 26, No. 2, 01.03.2006, p. 138-145.

Research output: Contribution to journalArticle

Nakamura, M, Takii, Y, Ito, M, Komori, A, Yokoyama, T, Shimizu-Yoshida, Y, Koyabu, M, Matsuyama, M, Mori, T, Kamihira, T, Daikoku, M, Migita, K, Yatsuhashi, H, Nozaki, N, Shimoda, S & Ishibashi, H 2006, 'Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis', Journal of Autoimmunity, vol. 26, no. 2, pp. 138-145. https://doi.org/10.1016/j.jaut.2005.10.007
Nakamura, Minoru ; Takii, Yasushi ; Ito, Masahiro ; Komori, Atsumasa ; Yokoyama, Terufumi ; Shimizu-Yoshida, Yuki ; Koyabu, Makiko ; Matsuyama, Mutsumi ; Mori, Tsuyoshi ; Kamihira, Takashi ; Daikoku, Manabu ; Migita, Kiyoshi ; Yatsuhashi, Hiroshi ; Nozaki, Naohito ; Shimoda, Shinji ; Ishibashi, Hiromi. / Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. In: Journal of Autoimmunity. 2006 ; Vol. 26, No. 2. pp. 138-145.
@article{f88a7c2a2eb24059a090421fa53484f9,
title = "Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis",
abstract = "The sustained antibody response to nuclear envelope gp210 antigen indicates a group of primary biliary cirrhosis (PBC) patients at high risk for the progression to end-stage hepatic failure. To address this issue, we immunohistochemically studied the expression of gp210 antigen in needle liver biopsy specimens from PBC patients using a monoclonal antibody specific for gp210 antigen. The specimens from autoimmune hepatitis (AIH), chronic viral hepatitis B (CHB) and C (CHC) patients served as disease controls. The expression of gp210 antigen was apparently increased on the nuclear envelope of biliary epithelial cells (BECs) of small bile ducts in almost all specimens from PBC. In contrast, the expression of gp210 antigen was negative in BECs of small bile ducts in normal liver, while relatively weak anti-gp210 immunostaining was observed in AIH, CHC and CHB. In addition, the degree of gp210 expression in BECs of small bile ducts was positively correlated to that of portal inflammation, interface hepatitis and lobular inflammation in PBC. These results indicate that the increased expression of gp210 in small bile ducts, which is probably associated with damage to BECs by inflammation, is possibly involved in autoimmune response to gp210 leading to the progression to end-stage hepatic failure in PBC.",
author = "Minoru Nakamura and Yasushi Takii and Masahiro Ito and Atsumasa Komori and Terufumi Yokoyama and Yuki Shimizu-Yoshida and Makiko Koyabu and Mutsumi Matsuyama and Tsuyoshi Mori and Takashi Kamihira and Manabu Daikoku and Kiyoshi Migita and Hiroshi Yatsuhashi and Naohito Nozaki and Shinji Shimoda and Hiromi Ishibashi",
year = "2006",
month = "3",
day = "1",
doi = "10.1016/j.jaut.2005.10.007",
language = "English",
volume = "26",
pages = "138--145",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis

AU - Nakamura, Minoru

AU - Takii, Yasushi

AU - Ito, Masahiro

AU - Komori, Atsumasa

AU - Yokoyama, Terufumi

AU - Shimizu-Yoshida, Yuki

AU - Koyabu, Makiko

AU - Matsuyama, Mutsumi

AU - Mori, Tsuyoshi

AU - Kamihira, Takashi

AU - Daikoku, Manabu

AU - Migita, Kiyoshi

AU - Yatsuhashi, Hiroshi

AU - Nozaki, Naohito

AU - Shimoda, Shinji

AU - Ishibashi, Hiromi

PY - 2006/3/1

Y1 - 2006/3/1

N2 - The sustained antibody response to nuclear envelope gp210 antigen indicates a group of primary biliary cirrhosis (PBC) patients at high risk for the progression to end-stage hepatic failure. To address this issue, we immunohistochemically studied the expression of gp210 antigen in needle liver biopsy specimens from PBC patients using a monoclonal antibody specific for gp210 antigen. The specimens from autoimmune hepatitis (AIH), chronic viral hepatitis B (CHB) and C (CHC) patients served as disease controls. The expression of gp210 antigen was apparently increased on the nuclear envelope of biliary epithelial cells (BECs) of small bile ducts in almost all specimens from PBC. In contrast, the expression of gp210 antigen was negative in BECs of small bile ducts in normal liver, while relatively weak anti-gp210 immunostaining was observed in AIH, CHC and CHB. In addition, the degree of gp210 expression in BECs of small bile ducts was positively correlated to that of portal inflammation, interface hepatitis and lobular inflammation in PBC. These results indicate that the increased expression of gp210 in small bile ducts, which is probably associated with damage to BECs by inflammation, is possibly involved in autoimmune response to gp210 leading to the progression to end-stage hepatic failure in PBC.

AB - The sustained antibody response to nuclear envelope gp210 antigen indicates a group of primary biliary cirrhosis (PBC) patients at high risk for the progression to end-stage hepatic failure. To address this issue, we immunohistochemically studied the expression of gp210 antigen in needle liver biopsy specimens from PBC patients using a monoclonal antibody specific for gp210 antigen. The specimens from autoimmune hepatitis (AIH), chronic viral hepatitis B (CHB) and C (CHC) patients served as disease controls. The expression of gp210 antigen was apparently increased on the nuclear envelope of biliary epithelial cells (BECs) of small bile ducts in almost all specimens from PBC. In contrast, the expression of gp210 antigen was negative in BECs of small bile ducts in normal liver, while relatively weak anti-gp210 immunostaining was observed in AIH, CHC and CHB. In addition, the degree of gp210 expression in BECs of small bile ducts was positively correlated to that of portal inflammation, interface hepatitis and lobular inflammation in PBC. These results indicate that the increased expression of gp210 in small bile ducts, which is probably associated with damage to BECs by inflammation, is possibly involved in autoimmune response to gp210 leading to the progression to end-stage hepatic failure in PBC.

UR - http://www.scopus.com/inward/record.url?scp=31344445698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31344445698&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2005.10.007

DO - 10.1016/j.jaut.2005.10.007

M3 - Article

VL - 26

SP - 138

EP - 145

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 2

ER -